8-K 1 d8k.htm FORM 8-K FILED 9/23/2002 Prepared by R.R. Donnelley Financial -- Form 8-K filed 9/23/2002
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
 
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
 
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
SEPTEMBER 23, 2002
 
 
KOSAN BIOSCIENCES INCORPORATED
(Exact name of registrant specified in its charter)
 
 
DELAWARE
   
000-31633
     
94-3217016
(State or other
jurisdiction of
incorporation)
   
(Commission
File Number)
     
(IRS Employee
Identification No.)
 
 
3832 BAY CENTER PLACE HAYWARD, CA 94545
(Address of principal executive offices) (Zip Code)
 
 
REGISTRANT’S TELEPHONE, INCLUDING AREA CODE: (510) 732-8400

 
Item 5.    OTHER EVENTS
 
On September 23, 2002, the Company issued the press release attached to this Form as Exhibit 99.1 and such press release is incorporated herein by reference.
 
Item 7.    FINANCIAL STATEMENTS AND EXHIBITS
 
(c)  EXHIBITS
 
99.1    Press Release dated September 23, 2002.

 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
KOSAN BIOSCIENCES INCORPORATED
(Registrant)
By
  
/S/    DANIEL V. SANTI, M.D., PH.D        
   
   
Daniel V. Santi, M.D., Ph.D.
Chairman and Chief Executive Officer
 
 
Dated:  September 23, 2002

 
EXHIBIT INDEX
 
EXHIBIT
     
99.1
   
Press Release dated September 23, 2002.